Welcome to LookChem.com Sign In|Join Free

CAS

  • or

57060-86-3

Post Buying Request

57060-86-3 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

57060-86-3 Usage

General Description

Methyl 1,2,3,4-tetrahydroisoquinoline-3-carboxylate is a specific type of chemical compound classified within the tetrahydroisoquinoline family. It has a highly specific structure that follows its name: a cyclical arrangement with a methyl ester attached, that is derived from the isoquinoline alkaloid chemical group. While there is not much information about it, the tetrahydroisoquinoline group of compounds is notable for their presence in a variety of biological organisms and for their use in making other compounds in both pharmaceutical applications and organic chemistry research. The specific uses and properties of "Methyl 1,2,3,4-tetrahydroisoquinoline-3-carboxylate", however, may vary based on the exact arrangement and attachments of its structure.

Check Digit Verification of cas no

The CAS Registry Mumber 57060-86-3 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 5,7,0,6 and 0 respectively; the second part has 2 digits, 8 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 57060-86:
(7*5)+(6*7)+(5*0)+(4*6)+(3*0)+(2*8)+(1*6)=123
123 % 10 = 3
So 57060-86-3 is a valid CAS Registry Number.

57060-86-3SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 17, 2017

Revision Date: Aug 17, 2017

1.Identification

1.1 GHS Product identifier

Product name Methyl 1,2,3,4-tetrahydroisoquinoline-3-carboxylate

1.2 Other means of identification

Product number -
Other names methyl R-1,2,3,4-tetrahydroisoquinoline-3-carboxylate

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:57060-86-3 SDS

57060-86-3Relevant articles and documents

New four-component Ugi-type reaction. Synthesis of 3-methyl-1-oxo-1,3,4,6, 11,11a-hexahydro-2H-pyrazino[1,2-b]isoquinoline-3-carboxamides

Ilyn, Alexey P.,Trifilenkov, Andrey S.,Kovrigin, Denis I.,Yudin, Michail V.,Ivachtchenko, Alexandre V.

, p. 107 - 110 (2006)

A small-sized library of novel 3,4,11,11a-tetrahydro-2H-pyrazino[1,2-b] isoquinolin-1(6H)-ones is synthesized. Key synthetic step is based on a new variant of Ugi four component reaction using bifunctional keto acids, amine and isocyanide as starting mate

NATURAL KILLER CELLS

-

Page/Page column 91-92; 98, (2020/01/24)

This invention relates to Natural Killer (NK) cell populations, to methods of producing the same and therapeutic applications thereof. More specifically, the invention relates to the expansion of IMK cells by increasing the expression of specific transcription factors associated with NK cell production.

Gene delivery system

-

Paragraph 0088; 0089, (2017/10/27)

The invention discloses a preparation method of a gene nano-liposome carrier Isoquinoline-3-acyl-RGDV(IRV) and an IRV/STAT3-siRNA gene delivery system. The IRV/STAT3-siRNA gene delivery system is composed of liposome carriers IRV and STAT3-siRNA, protamine and calf thymus DNA in a proportion, and has slow release and targeting effects. The cell transfection efficiency, the in-vitro anti-tumor activity, and the gene silencing efficiency and a cell action mechanism on the mRNA level and the protein level of a compound are evaluated with the lung cancer A549 cell strain as a model, and the result shows the IRV/STAT3-siRNA gene delivery system has more excellent anti-tumor activity and gene silencing efficiency compared with control groups. According to the system, the anti-tumor activity of the IRV/STAT3-siRNA gene delivery system is evaluated with an S180 ascites tumor mouse as a model, and the result shows that a 100% IRV/STAT3-siRNA group has an anti-tumor effect.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 57060-86-3